Stock DNA
Pharmaceuticals & Biotechnology
ILS 7 Million ()
NA (Loss Making)
NA
0.00%
-1.97
111.90%
-0.93
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2016)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
36.33%
0%
36.33%
6 Months
28.77%
0%
28.77%
1 Year
-15.0%
0%
-15.0%
2 Years
-16.43%
0%
-16.43%
3 Years
-54.17%
0%
-54.17%
4 Years
-88.84%
0%
-88.84%
5 Years
-96.55%
0%
-96.55%
Erech Finance Cahalacha Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.55%
EBIT Growth (5y)
8.20%
EBIT to Interest (avg)
-20.09
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-6.33
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.39
EV to EBIT
-2.84
EV to EBITDA
-2.86
EV to Capital Employed
2.39
EV to Sales
23.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-84.06%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY
Dec'16
Dec'15
Change(%)
Net Sales
0.00
0.10
-100.00%
Operating Profit (PBDIT) excl Other Income
-2.30
-2.50
8.00%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.20
-2.50
12.00%
Operating Profit Margin (Excl OI)
-179,769.20%
-47,905.70%
-13,186.35%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2016 is -100.00% vs 0.00% in Dec 2015
Consolidated Net Profit
YoY Growth in quarter ended Dec 2016 is 12.00% vs 87.24% in Dec 2015
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
0.10
0.20
-50.00%
Operating Profit (PBDIT) excl Other Income
-4.30
-5.00
14.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.80
-8.30
18.07%
Operating Profit Margin (Excl OI)
-69,153.10%
-34,392.00%
-3,476.11%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -50.00% vs -50.00% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 18.07% vs 66.67% in Dec 2024






